Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma (DLBCL) in clinical trials.
Ashley Marton
No relevant relationships to disclose
Sarit E. Assouline
Honoraria - Celgene; Roche
Research Funding - Novartis; Roche
Abbas Kezouh
No relevant relationships to disclose